KOPRI Repository

Ohioensin F suppresses TNF-α-induced adhesion molecule expression by inactivation of the MAPK, Akt and NF-κB pathways in vascular smooth muscle cells

Cited 22 time in wos
Cited 19 time in scopus

Full metadata record

DC Field Value Language
dc.contributor.authorHye-Eun Byeon-
dc.contributor.authorYim, Joung Han-
dc.contributor.authorSuhkneung Pyo-
dc.contributor.authorLee, Hong Kum-
dc.contributor.authorSung Hee Um-
dc.date.accessioned2018-03-20T13:48:15Z-
dc.date.available2018-03-20T13:48:15Z-
dc.date.issued2012-
dc.identifier.urihttps://repository.kopri.re.kr/handle/201206/6284-
dc.description.abstractThe expression of cell adhesion molecules on vascular smooth muscle cells is central to leukocyte re- 23 cruitment and progression of atherosclerotic disease. Ohioensin F, a chemical compound of the Antarctic 24 moss Polytrichastrum alpinum, exhibited inhibitory activity against protein tyrosine phosphatase 1B and an- 25 tioxidant activity. However, published scientific information regarding other biological activities and phar- 26 macological function of ohioensin F is scarce. In the present study, we aimed to examine the in vitro 27 effects of ohioensin F on the ability to suppress TNF-α-induced adhesion molecule expression in vascular 28 smooth muscle cells (VSMCs). 29 Main methods: The inhibitory effect of ohioensin F on TNF-α-induced upregulation in expression of adhesion 30 molecules was investigated by enzyme-linked immunosorbent assay, cell adhesion assay, RT- PCR, western 31 blot analysis, immunofluorescence, and transfection and reporter assay, respectively. 32 Key findings: Pretreatment of VSMCs with ohioensin F at nontoxic concentrations of 0.1?10 μg/ml dose- 33 dependently inhibited TNF-α-induced expression of vascular cell adhesion molecule-1 (VCAM-1) and inter- 34 cellular adhesion molecule-1 (ICAM-1). In addition, ohioensin F suppressed adhesion of THP-1 monocytes to 35 TNF-α-stimulated VSMCs. Ohioensin F reduced TNF-α-induced production of intracellular lpinum, exhibited inhibitory activity against protein tyrosine phosphatase 1B and an- 25 tioxidant activity. However, published scientific information regarding other biological activities and phar- 26 macological function of ohioensin F is scarce. In the present study, we aimed to examine the in vitro 27 effects of ohioensin F on the ability to suppress TNF-α-induced adhesion molecule expression in vascular 28 smooth muscle cells (VSMCs). 29 Main methods: The inhibitory effect of ohioensin F on TNF-α-induced upregulation in expression-
dc.languageEnglish-
dc.publisherElesevier-
dc.subjectPharmacology & Pharmacy-
dc.titleOhioensin F suppresses TNF-α-induced adhesion molecule expression by inactivation of the MAPK, Akt and NF-κB pathways in vascular smooth muscle cells-
dc.title.alternative평활근에서 오하이오신 f의 TNF-a 저해활성-
dc.typeArticle-
dc.identifier.bibliographicCitationHye-Eun Byeon, et al. 2012. "Ohioensin F suppresses TNF-α-induced adhesion molecule expression by inactivation of the MAPK, Akt and NF-κB pathways in vascular smooth muscle cells". <em>Life Sciences</em>, 90(11): 396-406.-
dc.citation.titleLife Sciences-
dc.citation.volume90-
dc.citation.number11-
dc.identifier.doi10.1016/j.lfs.2011.12.017-
dc.citation.startPage396-
dc.citation.endPage406-
dc.description.articleClassificationSCI-
dc.description.jcrRateJCR 2010:39.62264150943396-
dc.subject.keywordAnti-inflammation-
dc.subject.keywordMAPK-
dc.subject.keywordNF-κB-
dc.subject.keywordOhioensin F-
dc.subject.keywordVascular cell adhesion molecul-
dc.subject.keywordResearch & Experimental Medicine-
dc.identifier.localId2012-0133-
dc.identifier.scopusid2-s2.0-84862788872-
dc.identifier.wosid000301911200003-
Appears in Collections  
2011-2013, Utilization of novel metabolites from polar organisms (11-13) / Yim, Joung Han (PE11060, PE12040, PE13040)
Files in This Item

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse